PharmAla Announces Changes to Board of Directors - Pharmala Biotech Hldgs (OTC:MDXXF)

PharmAla Announces Changes to Board of Directors

PharmAla announces the resignation of Dr. Malik Slassi and the appointment of Mr Lennie Ryer to its board....

PharmAla Announces Changes to Board of Directors - Pharmala Biotech Hldgs (OTC:MDXXF)

TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE:MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce changes to the makeup of its Board of Directors. Effective Monday, February 9, 2026, PharmAla regretfully accepts the resignation of Dr. Malik Slas…